ArticleFrontiers in oncology2019

Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the

Vlad Moisoiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.